Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/IIa Trial of VTD-panobinostat Treatment and Panobinostat Maintenance in Relapsed and Relapsed/Refractory Multiple Myeloma Patients

NCT02145715 is registered in ClinicalTrials.gov with Prof Jamie Cavenagh as lead sponsor.

NCT NCT02145715
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02145715 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/IIa Trial of VTD-panobinostat Treatment and Panobinostat Maintenance in Relapsed and Relapsed/Refractory Multiple Myeloma Patients
Lead sponsor
Prof Jamie Cavenagh
Phase
Phase 1/2
Overall status
Unknown status
Start date
January 31, 2013
Completion date
January 31, 2016
Enrollment
54 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma